Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage
Molecular Therapy · 2025
DOI: 10.1016/j.ymthe.2025.06.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Qiong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Ear In…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Caspase 1, Phosphate-Binding Proteins, Ear, Inner. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, School of Medicine, Shanghai Jiao Tong University, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Sudden sensorineural hearing loss (SSNHL) is a prevalent condition in otolaryngology with poorly understood mechanisms. Inner ear labyrinthine hemorrhage (IELH) is a potentially significant cause. Our study focused on the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation following IELH and the protective role of the NLRP3 inhibitor CY-09. In mice with IELH, significant increases in hearing thresholds and vestibular dysfunction were observed compared with control groups. The activation of the NLRP3 inflammasome and other pro-inflammatory factors were markedly elevated, leading to potential damage in cochlear and vestibular hair cells via the Gasdermin D (GSDMD)-mediated pyroptosis pathway. Treatment with CY-09 significantly ameliorated hearing loss and vestibular dysfunction via inhibition of the NLRP3 inflammasome and associated cell pyroptosis. These results highlight the critical roles of the NLRP3 inflammasome and pyroptosis in IELH-induced SSNHL and suggest the NLRP3/caspase-1/GSDMD pathway as a therapeutic target for managing this condition. This study offers a new theoretical basis for the potential clinical management of SSNHL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200…
- Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Shanghai Key Laboratory of Translational Medicine in Ear and Nose Diseases, Shanghai 200092, China; Diagnosis and Treatment Center…
Förderung
- National Key Research and Development Program of China
- School of Medicine, Shanghai Jiao Tong University
- Key Research and Development Projects of Shaanxi Province
- National Natural Science Foundation of China
Zitieren
APA
Wu, Q., Xu, M., Yao, Y., Gong, T., Zhang, Q., Jin, Y., Yang, J., & Zhang, Q. (2025). Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.06.034
Vancouver
Wu Q, Xu M, Yao Y, Gong T, Zhang Q, Jin Y, et al. Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.06.034
BibTeX
@article{Wu2025,
author = {Wu, Qiong and Xu, Mingwei and Yao, Yuan and Gong, Tianyu and Zhang, Qin and Jin, Yulian and Yang, Jun and Zhang, Qing},
title = {Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage},
journal = {Molecular Therapy},
year = {2025},
doi = {10.1016/j.ymthe.2025.06.034}
}
EUVIMED